Literature DB >> 10539093

Efficacy and mode of action of an immunomodulator herbal preparation containing Echinacea, wild indigo, and white cedar.

P Wüstenberg, H H Henneicke-von Zepelin, G Köhler, U Stammwitz.   

Abstract

Using the example of an allopathic herbal combined preparation containing Echinacea root, wild indigo root, and white cedar leaf tips (Echinaceae radix + Baptisiae tinctoriae radix + Thujae occidentalis herba = Esberitox N), the efficacy and mode of action of a phytoimmunomodulator, or immune system enhancer, is described. Efficacy of the immunomodulator has been demonstrated in studies of acute viral respiratory tract infections and infections requiring antibiotic therapy. In a recent study compliant to GCP, the therapeutic superiority of the herbal immunomodulator over placebo was confirmed as statistically significant and clinically relevant. The present overview describes a model of the antigen-independent mode of action of phytoimmunomodulation ("immunobalancing").

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10539093

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  4 in total

1.  Thuja occidentalis (Arbor vitae): A Review of its Pharmaceutical, Pharmacological and Clinical Properties.

Authors:  Belal Naser; Cornelia Bodinet; Martin Tegtmeier; Ulrike Lindequist
Journal:  Evid Based Complement Alternat Med       Date:  2005-02-09       Impact factor: 2.629

Review 2.  Tracking Change: A Look at the Ecological Footprint of Antibiotics and Antimicrobial Resistance.

Authors:  Patricia L Keen; David M Patrick
Journal:  Antibiotics (Basel)       Date:  2013-03-27

Review 3.  Complementary and integrative treatments: rhinosinusitis.

Authors:  Malcolm B Taw; Chau T Nguyen; Marilene B Wang
Journal:  Otolaryngol Clin North Am       Date:  2013-04-28       Impact factor: 3.346

4.  Effects of echinacea on the frequency of upper respiratory tract symptoms: a randomized, double-blind, placebo-controlled trial.

Authors:  Joelle O'Neil; Susan Hughes; Andrea Lourie; John Zweifler
Journal:  Ann Allergy Asthma Immunol       Date:  2008-04       Impact factor: 6.347

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.